Table 2 Patient experiences and satisfaction with antifibrotic treatment after three and six months in the overall group (n = 75)

1.6 (1.6)

1.6 (1.8)

0.0 (− 0.3–0.5)

0.70

1.8 (2.0)

1.6 (2.1)

0.2 (− 0.4–0.6)

0.57

2.9 (1.6)

2.7 (1.7)

0.2 (− 0.1–0.6)

0.18

2.1 (1.8)

2.1 (1.9)

0.0 (−0.4–0.5)

0.90

2.0 (0.9)

2.0 (1.1)

0.0 (−0.4–0.5)

0.84

3.1 (1.1)

2.9 (1.2)

0.2 (−0.3–0.5)

0.44

3.9 (0.5)

3.8 (0.5)

0.1 (−0.1–0.2)

0.38

6.4 (4.2)

5.8 (4.7)

0.6 (−0.2–1.4)

0.14

9.5 (11.1)

8.7 (9.3)

0.8 (−1.6–3.2)

0.51